Who are Metadoxine extended release's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/metadoxine-extended-release.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Metadoxine extended release — Competitive Intelligence Brief

Metadoxine extended release (Metadoxine extended release) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B6 derivative / Acetaldehyde metabolism enhancer. Area: Hepatology / Addiction Medicine.

marketed Vitamin B6 derivative / Acetaldehyde metabolism enhancer Hepatology / Addiction Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Metadoxine extended release (Metadoxine extended release) — Alcobra Ltd.. Metadoxine is a combination of pyridoxine (vitamin B6) and L-2-aminoethanol that enhances acetaldehyde metabolism and reduces its toxic accumulation in alcohol-related disorders.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Metadoxine extended release TARGET	Metadoxine extended release	Alcobra Ltd.	marketed	Vitamin B6 derivative / Acetaldehyde metabolism enhancer

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B6 derivative / Acetaldehyde metabolism enhancer class)

Alcobra Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Metadoxine extended release — Competitive Intelligence Brief. https://druglandscape.com/ci/metadoxine-extended-release. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab